Management of Hospital-Acquired Pneumonia with Negative Cultures

Initial Risk Assessment and Empiric Therapy Selection

The European Respiratory Society recommends using narrow-spectrum antibiotics for patients with early-onset HAP without septic shock or other risk factors for MDR pathogens 1, 3
For low-risk patients, recommended antibiotic options include ertapenem, ceftriaxone, cefotaxime, moxifloxacin, and levofloxacin 1
The European Respiratory Society suggests using broad-spectrum empiric therapy for high-risk patients, including those with septic shock 2
Recommended regimens for high-risk patients include anti-pseudomonal β-lactam plus coverage for MRSA if risk factors are present 1

Clinical reassessment at 48-72 hours is essential, even with negative cultures, to evaluate clinical response using temperature trends, white blood cell count, chest X-ray findings, oxygenation parameters, and hemodynamic stability 1, 2, 4, 5
If clinical improvement is observed, consider de-escalation of antibiotics despite negative cultures 1, 2, 3

A 7-8 day course of antibiotics is recommended for uncomplicated HAP with good clinical response 2, 4
Longer courses may be needed for patients with immunodeficiency, lung abscess, empyema, or inadequate initial empiric therapy 1, 2, 4

Failure to de-escalate antibiotics despite clinical improvement contributes to antimicrobial resistance, according to the European Respiratory Society 1, 2, 4
Delayed reassessment may lead to prolonged unnecessary antibiotic exposure, as stated by the European Respiratory Society and the American Journal of Respiratory and Critical Care Medicine 1, 4, 5

For patients with negative cultures but persistent symptoms, consider non-infectious causes of pulmonary infiltrates, such as heart failure or pulmonary embolism, as suggested by the American Journal of Respiratory and Critical Care Medicine 5
The value of negative lower respiratory tract cultures is highest when obtained before antibiotic initiation or changes within the previous 72 hours, according to the American Journal of Respiratory and Critical Care Medicine 4, 5